Literature DB >> 19583707

Reversibility of acute intermediate phase bilirubin encephalopathy.

Thor Willy Ruud Hansen1, Lutz Nietsch, Elisabeth Norman, Jesper Vandborg Bjerre, Jean-Michel Hascoet, Khalaf Mreihil, Finn Ebbesen.   

Abstract

AIM: To show the potential for reversing acute intermediate to advanced phase bilirubin encephalopathy.
METHODS: Case studies.
RESULTS: Six extremely jaundiced infants had symptoms of intermediate to advanced phase acute bilirubin encephalopathy. The infants were treated aggressively. Two patients had brain magnetic resonance imaging showing increased signals in the globus pallidus. On follow-up, all infants are neurologically normal.
CONCLUSIONS: Intermediate-to-advanced stage acute bilirubin encephalopathy may occasionally be reversible. These cases provide a strong argument in favour of rapid and aggressive intervention in infants presenting with extreme jaundice and neurological symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19583707     DOI: 10.1111/j.1651-2227.2009.01409.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  13 in total

1.  William A Silverman lecture.

Authors:  D K Stevenson
Journal:  J Perinatol       Date:  2013-08-22       Impact factor: 2.521

2.  Early formation of bilirubin isomers during phototherapy for neonatal jaundice: effects of single vs. double fluorescent lamps vs. photodiodes.

Authors:  Khalaf Mreihil; Poul Madsen; Britt Nakstad; Jūratė Šaltytė Benth; Finn Ebbesen; Thor Willy Ruud Hansen
Journal:  Pediatr Res       Date:  2015-03-20       Impact factor: 3.756

3.  Quantitative ADC in bilirubin encephalopathy.

Authors:  Jon F Watchko; Michael J Painter; Ashok Panigrahy
Journal:  Jpn J Radiol       Date:  2013-02-02       Impact factor: 2.374

4.  A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings.

Authors:  B O Olusanya; I F Iskander; T M Slusher; R P Wennberg
Journal:  J Perinatol       Date:  2016-03-03       Impact factor: 2.521

5.  Double versus single intensive phototherapy with LEDs in treatment of neonatal hyperbilirubinemia.

Authors:  M L Donneborg; P K Vandborg; B M Hansen; M Rodrigo-Domingo; F Ebbesen
Journal:  J Perinatol       Date:  2017-11-02       Impact factor: 2.521

Review 6.  Apnea in acute bilirubin encephalopathy.

Authors:  Sanjiv B Amin; Vinod K Bhutani; Jon F Watchko
Journal:  Semin Perinatol       Date:  2014-09-17       Impact factor: 3.300

7.  Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in vivo in mice.

Authors:  Giulia Bortolussi; Gabriele Baj; Simone Vodret; Giulia Viviani; Tamara Bittolo; Andrés F Muro
Journal:  Dis Model Mech       Date:  2014-07-25       Impact factor: 5.758

8.  Ex vivo (1)H nuclear magnetic resonance spectroscopy reveals systematic alterations in cerebral metabolites as the key pathogenetic mechanism of bilirubin encephalopathy.

Authors:  Wenyi Hu; Xiaojie Cheng; Xinjian Ye; Liangcai Zhao; Yanan Huang; Huanle Zhu; Zhihan Yan; Xuebao Wang; Xiaojie Wang; Guanghui Bai; Hongchang Gao
Journal:  Mol Brain       Date:  2014-11-26       Impact factor: 4.041

Review 9.  Review of bilirubin neurotoxicity II: preventing and treating acute bilirubin encephalopathy and kernicterus spectrum disorders.

Authors:  Steven M Shapiro; Sean M Riordan
Journal:  Pediatr Res       Date:  2019-10-03       Impact factor: 3.756

10.  Neurobehavior of term neonates with neonatal hyperbilirubinemia.

Authors:  Thirunavukkarasu Arun Babu; B Vishnu Bhat; Noyal Mariya Joseph
Journal:  J Pediatr Neurosci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.